Morningstar US Small Growth Rating → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free MSGR Stock Alerts $13.91 0.00 (0.00%) (As of 05/12/2023) Add Compare Share Share RatingsStock AnalysisRatingsStock AnalysisRatings Morningstar US Small Growth Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MSGR Aggregate RatingModerate Buy2.66Holdings in MSGR have an aggregate rating of Moderate Buy based on 210 analyst ratings issued in the past year covering 23 companies (99.9% of the portfolio).MSGR Aggregate Price Target$33.59141.47% UpsideHigh Prediction$48.62Average Prediction$33.59Low Prediction$20.53Holdings in MSGR have an aggregate price target of $33.59 and a range of $20.53 to $48.62 covering 23 companies (99.9% of the portfolio).MSGR Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy9 Buy rating(s)Moderate Buy9 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Morningstar US Small Growth Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 MSGR Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.06%VRTXVertex Pharmaceuticals$422.78+0.9%4 of 5 stars2.48$432.18 2.2%25Earnings ReportAnalyst Forecast7.99%SCLXScilex$0.75-9.7%2 of 5 stars3.00$6.00 704.9%2News CoverageGap Up7.01%ARCTArcturus Therapeutics$27.26+1.8%2 of 5 stars3.00$64.86 137.9%7Analyst ForecastShort Interest ↑News Coverage6.93%BGNEBeiGene$161.13-4.5%3 of 5 stars2.80$251.93 56.4%10Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage6.62%ALNYAlnylam Pharmaceuticals$150.47-0.6%4 of 5 stars2.59$216.19 43.7%17Analyst ForecastShort Interest ↑Analyst Revision6.44%MRNAModerna$117.31-4.4%3 of 5 stars2.25$126.89 8.2%16Analyst ForecastInsider SellingNews Coverage6.17%BNTXBioNTech$91.67-0.4%2 of 5 stars2.27$118.82 29.6%11Analyst ForecastShort Interest ↑Analyst RevisionNews Coverage5.97%SRPTSarepta Therapeutics$131.82-0.4%4 of 5 stars2.79$160.60 21.8%145.78%PTCTPTC Therapeutics$32.25+3.9%2 of 5 stars1.92$33.67 4.4%13Positive News4.94%MRVIMaravai LifeSciences$10.46+6.1%2 of 5 stars2.70$11.44 9.4%10Analyst ForecastNews CoverageHigh Trading Volume4.29%NTLAIntellia Therapeutics$24.46-1.6%4 of 5 stars2.69$66.77 173.0%13Analyst ForecastNews Coverage4.24%IONSIonis Pharmaceuticals$39.08-1.0%4 of 5 stars2.71$59.54 52.4%14Earnings ReportAnalyst ForecastInsider SellingShort Interest ↓3.19%RNAAvidity Biosciences$25.96-4.2%1 of 5 stars3.00$38.29 47.5%7Upcoming EarningsAnalyst ForecastInsider SellingNews CoveragePositive News3.19%CVACCureVac$2.91-2.3%3 of 5 stars2.00$8.33 186.4%53.18%ARWRArrowhead Pharmaceuticals$22.08-10.7%4 of 5 stars2.64$50.80 130.1%9Earnings ReportAnalyst ForecastShort Interest ↑News CoverageHigh Trading Volume2.95%ABUSArbutus Biopharma$2.88-2.0%1 of 5 stars3.00$4.33 50.5%3Short Interest ↑2.59%DYNDyne Therapeutics$26.00+0.2%3 of 5 stars3.13$37.75 45.2%8Short Interest ↑Analyst Revision2.17%GRTSGritstone bio$0.78-19.5%1 of 5 stars3.00$6.33 707.3%3Earnings ReportShort Interest ↑News CoverageGap Down2.10%SGMOSangamo Therapeutics$0.56+7.7%1 of 5 stars2.50$5.67 909.4%6Earnings ReportNews CoverageHigh Trading Volume1.84%STOKStoke Therapeutics$11.48-4.4%4 of 5 stars2.88$20.57 79.2%8Analyst ForecastShort Interest ↑Analyst RevisionNews Coverage1.53%HLVXHilleVax$13.84-1.1%3 of 5 stars3.00$30.67 121.6%3Analyst ForecastShort Interest ↑News Coverage1.52%PRQRProQR Therapeutics$1.98-1.0%2 of 5 stars3.00$3.60 81.8%4Analyst ForecastNews Coverage1.20%PEPGPepGen$14.01+5.0%2 of 5 stars3.00$24.67 76.1%2Short Interest ↑News Coverage This page (NYSEARCA:MSGR) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward Press[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Morningstar US Small Growth Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
